30 April 2024
Oxford Nanopore Technologies plc
(the "Company")
Publication of 2023 Annual Report and Notice of Annual General Meeting
Oxford Nanopore Technologies plc (LSE:ONT), the company behind a new generation of nanopore-based sequencing technology, today announces that it has published its Annual Report and Accounts for the year ended 31 December 2023 and its Notice of Annual General Meeting 2024.
In compliance with Listing Rule 9.6.1, copies of the following documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism
· Annual Report and Accounts for the year ended 31 December 2023 ("2023 ARA"); and
· Notice of Annual General Meeting 2024 ("2024 AGM Notice").
Printed copies of the 2023 ARA and 2024 AGM Notice, together with the Form of Proxy for use in connection with the 2024 Annual General Meeting, have been posted to shareholders who have requested hard copies. Electronic copies of the 2023 ARA and 2024 AGM Notice are available on the Investor Relations section of the Company's website at https://nanoporetech.com/about-us/investors.
The 2024 Annual General Meeting will be held at the Company's offices at Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ at 1.00pm on Monday, 10 June 2024. Further details regarding the arrangements for the 2024 Annual General Meeting can be found in the 2024 AGM Notice.
EXPLANATORY NOTE
For the purposes of complying with the Disclosure and Transparency Rules, the 2023 ARA being submitted to the National Storage Mechanism contains the following regulated information in unedited form:
· The principal risks and uncertainties facing the Company;
· The Directors' responsibility statement made in respect of the Financial Statements and Directors' Report contained in the 2023 ARA; and
· A statement regarding related party transactions.
[ENDS]
For further information please contact:
Oxford Nanopore Technologies plc
Hannah Coote, Company Secretary
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 120 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.
Oxford Nanopore devices sequence DNA and RNA directly and sequence short to ultra-long fragments of DNA, for a truly comprehensive picture of the genome. Data is streamed in real-time and can enable rapid insights. The technology is fully scalable - from pocket-sized to ultra-high throughput devices.
For more information please visit: www.nanoporetech.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
